Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Pennells

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
JAMA|July 17, 2012
Lipid-related markers and cardiovascular disease prediction, Emanuele Di Angelantonio, Pei Gao, et al.
European Journal of Preventive Cardiology|August 16, 2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OPKunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman, et al.
JAMA Cardiology|January 17, 2019
Cardiovascular Risk Factors Associated With Venous ThromboembolismJohn Gregson, Stephen Kaptoge, Thomas Bolton, et al.
The New England Journal of Medicine|October 5, 2012
C-reactive protein, fibrinogen, and cardiovascular disease prediction, Stephen Kaptoge, Emanuele Di Angelantonio, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
JAMA|July 8, 2015
Association of Cardiometabolic Multimorbidity With Mortality, Emanuele Di Angelantonio, Stephen Kaptoge, et al.
European Heart Journal|November 27, 2018
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studiesLisa Pennells, Stephen Kaptoge, Angela Wood, et al.
Circulation|October 31, 2022
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization AnalysesLiam Gaziano, Luanluan Sun, Matthew Arnold, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
JAMA|July 17, 2012
Lipid-related markers and cardiovascular disease prediction, Emanuele Di Angelantonio, Pei Gao, et al.
European Journal of Preventive Cardiology|August 16, 2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OPKunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman, et al.
JAMA Cardiology|January 17, 2019
Cardiovascular Risk Factors Associated With Venous ThromboembolismJohn Gregson, Stephen Kaptoge, Thomas Bolton, et al.
The New England Journal of Medicine|October 5, 2012
C-reactive protein, fibrinogen, and cardiovascular disease prediction, Stephen Kaptoge, Emanuele Di Angelantonio, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
JAMA|July 8, 2015
Association of Cardiometabolic Multimorbidity With Mortality, Emanuele Di Angelantonio, Stephen Kaptoge, et al.
European Heart Journal|November 27, 2018
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studiesLisa Pennells, Stephen Kaptoge, Angela Wood, et al.
Circulation|October 31, 2022
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization AnalysesLiam Gaziano, Luanluan Sun, Matthew Arnold, et al.
Pageof 5